MAPAP EXTRA STRENGTH

Generic: ACETAMINOPHEN

Manufacturer: Major Pharmaceuticals

Nonsteroidal Anti-inflammatory Drug [EPC]Corticosteroid [EPC]Benzodiazepine [EPC]Proton Pump Inhibitor [EPC]Vitamin C [EPC]
239,692
Total Reports
147,231
Serious Reports
46,943
Death Reports
30
Reported Reactions
Death Report Ratio: High (19.58%)

Patient Demographics

Male
79,024
Female
130,947

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for MAPAP EXTRA STRENGTH.

# Reaction Reports % of Total
1 OFF LABEL USE 21,672
6.0%
2 FATIGUE 19,959
5.5%
3 DRUG INEFFECTIVE 17,786
4.9%
4 PAIN 17,754
4.9%
5 NAUSEA 17,136
4.8%
6 HEADACHE 16,294
4.5%
7 TOXICITY TO VARIOUS AGENTS 14,611
4.1%
8 DYSPNOEA 14,181
3.9%
9 ARTHRALGIA 14,082
3.9%
10 PYREXIA 13,955
3.9%
11 VOMITING 13,604
3.8%
12 DIARRHOEA 13,049
3.6%
13 RASH 12,169
3.4%
14 INFUSION RELATED REACTION 10,764
3.0%
15 PNEUMONIA 10,721
3.0%
16 MALAISE 9,985
2.8%
17 CONDITION AGGRAVATED 9,504
2.6%
18 DIZZINESS 9,388
2.6%
19 ASTHENIA 9,372
2.6%
20 PRURITUS 9,289
2.6%
21 DEATH 8,966
2.5%
22 NASOPHARYNGITIS 8,951
2.5%
23 JOINT SWELLING 8,783
2.4%
24 RHEUMATOID ARTHRITIS 8,704
2.4%
25 WEIGHT INCREASED 8,449
2.3%
26 SINUSITIS 8,285
2.3%
27 HYPERTENSION 8,207
2.3%
28 FALL 8,205
2.3%
29 HYPERSENSITIVITY 8,056
2.2%
30 COMPLETED SUICIDE 7,992
2.2%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.